.Pharmacolibrary.Drugs.ATC.N.N05CC04 .Pharmacolibrary.Drugs.ATC.N.N05CC04| name: | Dichloralphenazone | |
| ATC code: | N05CC04 | |
| route: | oral | |
| compartments: | 1 | |
| dosage: | 100 | mg |
| volume of distribution: | 0.6 | L |
| clearance: | 2 | L/h |
| other parameters in model implementation | ||
Dichloralphenazone is a sedative-hypnotic compound composed of a 1:2 molar mixture of chloral hydrate and phenazone (antipyrine). It has been used primarily as an ingredient in combination medications for the short-term treatment of tension and vascular headaches (e.g., migraine). It is not widely used as a monotherapy and is rarely used today due to the availability of safer alternatives; its clinical use has declined in many countries.
No pharmacokinetic studies found in the literature for dichloralphenazone as a single entity. Estimates below are based on assumptions from its known components, typical clinical dosage, and standard oral absorption parameters in adults.